Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Metadata
Title
Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats
Authors
J. Hua
S. Suguro
S. Hirano
K. Sakamoto
I. Nagaoka
Publication date
01-03-2005
Publisher
Birkhäuser-Verlag
Published in
Inflammation Research / Issue 3/2005
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-004-1333-6

Other articles of this Issue 3/2005

Inflammation Research 3/2005 Go to the issue

Original Research Paper

Insight into the involvement of Kupffer cell-derived mediators in the hepatoprotective effect of glycine upon inflammation: study on rat precision-cut liver slices

Original Research Paper

Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats

Original Research Paper

The role of protein kinase C in regulating equine eosinophil adherence and superoxide production

Original Research Paper

Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production

Original Research Paper

Pharmacological characterization of P2X7 receptors in rat peritoneal cells

Original Research Paper

The influence of vitamin C on systemic markers of endothelial and inflammatory cell activation in smokers and non-smokers

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits